Research groups | group Volk
The group works on the implementation of new approaches in the diagnosis and treatment of immunological diseases. The spectrum ranges from the developement of biomarkers to monitor new therapeutics (phase I / II studies) to 'proof of concept' and 'investigator-induced' phase I / II studies of innovative immunotherapeutic approaches based on new pathogenetic findings.
In addition to the close networking with the other research groups of the institute, there is a close collaboration with clinical partners, in particular with the interdisciplinary clinical research groups located at the institute (Nephrology / transplantation medicine, intensive care, dermatology), as well as biotech companies, clinical research organisations (CRO Charité, Parexel) and the pharmaceutical industry (Bayer Schering Pharma, Biogen, Novartis, Nycomed, Roche, Johnson / Johnson, etc.).
Please click on the following picture to learn more about "Immunmonitoring at the Institute for Medical Immunology.
